Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Summary

Primary Objective: To assess the long-term safety of vatelizumab in MS patients Secondary Objective: To assess the long-term efficacy of vatelizumab

Timeline

Start

2015-02

Primary completion

2016-04

Completion

2016-07

Outcome

Outcome not reported

Stopped: “Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any safety concern.”

Drugs

Indications